Atrium Health Helps Pave Path Toward Clinical Research as a Care Option Targeting COVID-19 with Three New Clinical Trials Offering Outpatient Hope

Atrium Health Helps Pave Path Toward Clinical Research as a Care Option Targeting COVID-19 with Three New Clinical Trials Offering Outpatient Hope

Atrium Health, formerly the Carolinas HealthCare System, has been active on multiple fronts battling COVID-19. The nonprofit network of over 40 hospitals and over 900 care locations in North Carolina, South Carolina, and Georgia have also emerged as a leading player in the Southeast—if not nationwide—in the nascent but critically important clinical research as a care option movement. Research emerged as a critical care option to COVID-19, given there is now only one formally U.S. FDA approved product targeting COVID-19 (remdesivir) for hospitalized patients, and two others accepted (including dexamethasone) for more severe cases involving hospitalized patients who require breathing support as well as convalescent plasma via emergency use authorization. Much research deals with hospitalized patients, but the vast majority of COVID-19 patients are outpatient situations. Hence, Atrium Health launched three outpatient-focused clinical trials that happen to be the only such trials in the entire region. They include 1) Gilead Remdesivir for outpatient use, 2) Regeneron Trial, and 3) Regeneron Prophylaxis Trial. Atrium Heath seeks to demonstrate via these trials that these therapies can ...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee